That was Kush, not Nitya. BTW I can confirm Cyrus et al are preparing a conference call with investors next week. I wanted to ask if he has a copy of The Art of War on his coffee table but refrained. He is disciplined and is very experienced vis a vis biopharma strategy; we should be comforted that he is at the helm at this moment. I am optimistic 2023 rings in something beyond the new year.